These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1199 related articles for article (PubMed ID: 30857539)
1. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539 [TBL] [Abstract][Full Text] [Related]
2. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861 [TBL] [Abstract][Full Text] [Related]
3. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling. Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949 [TBL] [Abstract][Full Text] [Related]
4. TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions. Wang Y; Wu C; Zhang C; Li Z; Zhu T; Chen J; Ren Y; Wang X; Zhang L; Zhou X Cancer Lett; 2018 Nov; 436():52-62. PubMed ID: 30118844 [TBL] [Abstract][Full Text] [Related]
5. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling. Wu Q; Zhao Y; Wang P Biomed Pharmacother; 2018 Mar; 99():278-285. PubMed ID: 29353201 [TBL] [Abstract][Full Text] [Related]
6. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010 [TBL] [Abstract][Full Text] [Related]
7. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis. Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422 [TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766 [TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling. Jia L; Song Q; Zhou C; Li X; Pi L; Ma X; Li H; Lu X; Shen Y PLoS One; 2016; 11(1):e0147157. PubMed ID: 26784960 [TBL] [Abstract][Full Text] [Related]
10. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470 [TBL] [Abstract][Full Text] [Related]
11. A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Ma H; Chang H; Yang W; Lu Y; Hu J; Jin S Mol Cancer; 2020 Jan; 19(1):4. PubMed ID: 31907020 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Lee TL; Yeh J; Van Waes C; Chen Z Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer. Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53. Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250 [TBL] [Abstract][Full Text] [Related]
15. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Li F; Shanmugam MK; Chen L; Chatterjee S; Basha J; Kumar AP; Kundu TK; Sethi G Cancer Prev Res (Phila); 2013 Aug; 6(8):843-54. PubMed ID: 23803415 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016 [TBL] [Abstract][Full Text] [Related]
17. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex. Verduci L; Ferraiuolo M; Sacconi A; Ganci F; Vitale J; Colombo T; Paci P; Strano S; Macino G; Rajewsky N; Blandino G Genome Biol; 2017 Dec; 18(1):237. PubMed ID: 29262850 [TBL] [Abstract][Full Text] [Related]
18. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules. Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694 [TBL] [Abstract][Full Text] [Related]
19. Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer. Wang X; Ruan Y; Wang X; Zhao W; Jiang Q; Jiang C; Zhao Y; Xu Y; Sun F; Zhu Y; Xia S; Xu D Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 27976428 [TBL] [Abstract][Full Text] [Related]
20. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Sen B; Peng S; Woods DM; Wistuba I; Bell D; El-Naggar AK; Lai SY; Johnson FM Clin Cancer Res; 2012 Jan; 18(1):127-39. PubMed ID: 22090359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]